Cargando…
Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands
To overcome the side effects of and resistance to cisplatin, a variety of Pt(IV) prodrugs were designed and synthesized via different modifications including combination with lipid chains to increase hydrophobicity, conjugation with short peptide chains or nanoparticles to improve drug delivery, or...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191961/ https://www.ncbi.nlm.nih.gov/pubmed/30402082 http://dx.doi.org/10.1155/2018/8276139 |